Company CVAbout Solara Active Pharma Sciences Ltd 
Solara Active Pharma Sciences Ltd
Small Cap
Pharmaceuticals & Drugs
Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru.
Company Coordinates
Company Details
201 Devavrata Sector 17 Vashi, Navi Mumbai Mumbai Maharashtra : 400703
Registrar Details
Capital StructureCapital Structure
Present Equity Capital
INR 36.01 Cr
Number of Shares
3.6 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-May-2024
3.6
36.01
9000
10
Issued under ESOP Scheme
15-May-2024
4.8
48.00
11998755
10
Right Issues
09-Mar-2022
3.6
36.00
30000
10
Issued under ESOP Scheme
09-Feb-2022
3.6
35.97
20000
10
Issued under ESOP Scheme
12-Nov-2021
3.59
35.95
16500
10
Issued under ESOP Scheme
31-Mar-2021
3.59
35.93
20000
10
Issued under ESOP Scheme
30-Oct-2020
3.59
35.91
86500
10
Issued under ESOP Scheme
14-Sep-2020
3.58
35.82
360000
10
Issued under ESOP Scheme
01-Sep-2020
3.55
35.46
8600000
10
Conversion of Warrants
18-Aug-2020
2.69
26.86
8000
10
Issued under ESOP Scheme
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
40.7357
Mutual Funds
Held by 3 Schemes (1.28%)
FIIs
Held by 62 FIIs (14.67%)
Promoter with highest holding
Devicam Capital Llp (15.53%)
Highest Public shareholder
Spiracca Ventures Llp . (7.78%)
Individual Investors Holdings
21.92%
Board of Directors
Management
Designation
Remuneration
Aditya Puri
Chairman & Non Executive Dir.
4.0 lacs
Nirmal P Bhogilal
Independent Director
6.0 lacs
Vineeta Rai
Independent Director
8.0 lacs
RAJAGOPALAN RAMAKRISHNAN
Independent Non Exe. Director
8.0 lacs
Kausalya Santhanam
Independent Director
8.0 lacs
ANKUR NAND THADANI
Non Executive Director
0
Arun Kumar
Non Executive Director
0
S Hariharan
Executive Director & CFO
1.98 cr
Jitesh Devendra
Managing Director & CEO
2.3 cr
Poorvank Purohit
Managing Director & CEO
0
Rajendra Kumar Srivastava
Additional Director
0
Rajiv Vijay Naba
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Traded Goods
29.67
0%
Purchase of Traded Goods
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Ingredients
1,308.07
94.16%
Other Operating Income
50.76
3.65%
Services Income
30.33
2.18%
Pharmaceutical Ingredients
Pharmaceutical Ingredients
Other Operating Income
Other Operating Income
Services Income
Services Income
Stock DNARevenue and Profits:
Net Sales:
300 Cr
(Quarterly Results - Dec 2024)
Net Profit:
8 Cr
Pharmaceuticals & Drugs
INR 1,845 Cr (Small Cap)
NA (Loss Making)
33
0.00%
0.77
-32.34%
1.63
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
